These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9346948

  • 1. The Cys6 intermolecular disulfide bond and the collagen-like region of rat SP-A play critical roles in interactions with alveolar type II cells and surfactant lipids.
    McCormack FX, Pattanajitvilai S, Stewart J, Possmayer F, Inchley K, Voelker DR.
    J Biol Chem; 1997 Oct 31; 272(44):27971-9. PubMed ID: 9346948
    [Abstract] [Full Text] [Related]

  • 2. The longer isoform and Cys-1 disulfide bridge of rat surfactant protein A are not essential for phospholipid and type II cell interactions.
    Zhang M, Damodarasamy M, Elhalwagi BM, McCormack FX.
    Biochemistry; 1998 Nov 24; 37(47):16481-8. PubMed ID: 9843414
    [Abstract] [Full Text] [Related]

  • 3. Deletion mapping of N-terminal domains of surfactant protein A. The N-terminal segment is required for phospholipid aggregation and specific inhibition of surfactant secretion.
    McCormack FX, Damodarasamy M, Elhalwagi BM.
    J Biol Chem; 1999 Jan 29; 274(5):3173-81. PubMed ID: 9915857
    [Abstract] [Full Text] [Related]

  • 4. Interactions of pulmonary surfactant protein SP-A with monolayers of dipalmitoylphosphatidylcholine and cholesterol: roles of SP-A domains.
    Yu SH, McCormack FX, Voelker DR, Possmayer F.
    J Lipid Res; 1999 May 29; 40(5):920-9. PubMed ID: 10224161
    [Abstract] [Full Text] [Related]

  • 5. Surfactant protein A amino acids Glu195 and Arg197 are essential for receptor binding, phospholipid aggregation, regulation of secretion, and the facilitated uptake of phospholipid by type II cells.
    McCormack FX, Kuroki Y, Stewart JJ, Mason RJ, Voelker DR.
    J Biol Chem; 1994 Nov 25; 269(47):29801-7. PubMed ID: 7961972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epitope mapping for monoclonal antibodies identifies functional domains of pulmonary surfactant protein A that interact with lipids.
    Kuroki Y, McCormack FX, Ogasawara Y, Mason RJ, Voelker DR.
    J Biol Chem; 1994 Nov 25; 269(47):29793-800. PubMed ID: 7525589
    [Abstract] [Full Text] [Related]

  • 9. Role of the C-terminal domain of pulmonary surfactant protein A in binding to alveolar type II cells and regulation of phospholipid secretion.
    Murata Y, Kuroki Y, Akino T.
    Biochem J; 1993 Apr 01; 291 ( Pt 1)(Pt 1):71-6. PubMed ID: 8471056
    [Abstract] [Full Text] [Related]

  • 10. Alternate amino terminal processing of surfactant protein A results in cysteinyl isoforms required for multimer formation.
    Elhalwagi BM, Damodarasamy M, McCormack FX.
    Biochemistry; 1997 Jun 10; 36(23):7018-25. PubMed ID: 9188699
    [Abstract] [Full Text] [Related]

  • 11. Chimeras of surfactant proteins A and D identify the carbohydrate recognition domains as essential for phospholipid interaction.
    Ogasawara Y, McCormack FX, Mason RJ, Voelker DR.
    J Biol Chem; 1994 Nov 25; 269(47):29785-92. PubMed ID: 7961971
    [Abstract] [Full Text] [Related]

  • 12. The collagen-like region of surfactant protein A (SP-A) is required for correction of surfactant structural and functional defects in the SP-A null mouse.
    Ikegami M, Elhalwagi BM, Palaniyar N, Dienger K, Korfhagen T, Whitsett JA, McCormack FX.
    J Biol Chem; 2001 Oct 19; 276(42):38542-8. PubMed ID: 11504713
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Human surfactant protein A with two distinct oligomeric structures which exhibit different capacities to interact with alveolar type II cells.
    Hattori A, Kuroki Y, Sohma H, Ogasawara Y, Akino T.
    Biochem J; 1996 Aug 01; 317 ( Pt 3)(Pt 3):939-44. PubMed ID: 8760386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The role of pulmonary collectin N-terminal domains in surfactant structure, function, and homeostasis in vivo.
    Palaniyar N, Zhang L, Kuzmenko A, Ikegami M, Wan S, Wu H, Korfhagen TR, Whitsett JA, McCormack FX.
    J Biol Chem; 2002 Jul 26; 277(30):26971-9. PubMed ID: 12015304
    [Abstract] [Full Text] [Related]

  • 17. Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A.
    Kuroki Y, Shiratori M, Murata Y, Akino T.
    Biochem J; 1991 Oct 01; 279 ( Pt 1)(Pt 1):115-9. PubMed ID: 1930130
    [Abstract] [Full Text] [Related]

  • 18. Roles of collagenous domain and oligosaccharide moiety of pulmonary surfactant protein A in interactions with phospholipids.
    Kuroki Y, Akino T.
    Biochem Int; 1991 May 01; 24(2):225-33. PubMed ID: 1656980
    [Abstract] [Full Text] [Related]

  • 19. Ca(2+)-dependent binding of annexin IV to surfactant protein A and lamellar bodies in alveolar type II cells.
    Sohma H, Matsushima N, Watanabe T, Hattori A, Kuroki Y, Akino T.
    Biochem J; 1995 Nov 15; 312 ( Pt 1)(Pt 1):175-81. PubMed ID: 7492310
    [Abstract] [Full Text] [Related]

  • 20. Chemical modification of surfactant protein A alters high affinity binding to rat alveolar type II cells and regulation of phospholipid secretion.
    Kuroki Y, Mason RJ, Voelker DR.
    J Biol Chem; 1988 Nov 25; 263(33):17596-602. PubMed ID: 2846572
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.